Some physicians have urged their colleagues and medical societies to move professional conferences out of states that ...

Gender-affirming hormone therapy may reduce the risk of prostate cancer in transgender women, but it may also increase the risk of biochemical recurrence and bone metastases in patients with prostate ...

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults age 45 years and older who are at average risk of colorectal cancer.

Atezolizumab did not improve overall survival, progression-free survival, distant metastasis-free survival, or time to local failure.

Female physicians remain underrepresented among residents entering high-compensation specialties, data suggest.

A 2023 survey showed that 24% of Americans who used online pharmacies had been exposed to harmful or substandard medications.

Prior results from the SHAPE trial showed that simple hysterectomy was noninferior to radical hysterectomy for oncologic ...

Hypofractionated PMRT is safe and effective in breast cancer patients undergoing reconstruction and should be moved into ...

A machine learning survival model that selects patients for serious illness conversations can increase the rate of advance ...

Overall, researchers are estimating that there will be 310,720 new cases of invasive breast cancer and 56,500 new cases of ...

The HYPOSIB trial supports moderately hypofractionated radiotherapy with simultaneous boost as a standard-of-care option that ...

Medicaid expansion was associated with earlier diagnosis, more timely initiation of guideline-concordant care, and better ...